Cost-effectiveness of Maintenance Treatment with a Barrier-strengthe-ning Moisturizing Cream in Patients with Atopic Dermatitis in Finland, Norway and Sweden.
In conclusion, the barrier-strengthening moisturizer is cost-effective as maintenance therapy for patients with atopic dermatitis compared with a moisturizer with no active ingredients. PMID: 26304099 [PubMed - as supplied by publisher]
Conclusions and Relevance: Overlap in immune signaling pathways between AD and chronic pruritus, eczematous eruption of aging, allergic contact dermatitis, chronic hand eczema, alopecia areata, urticaria, eosinophilic annular erythema, bullous pemphigoid and papuloerythroderma of Ofuji make these conditions candidates for dupilumab therapy when standard treatments have failed or are contraindicated. While promising as a therapeutic option, off-label prescribing of dupilumab requires consideration of challenges in insurance authorization and out-of-pocket cost to the patient. PMID: 31693426 [PubMed - as supplied by publisher]
Conditions: Atopic Dermatitis; Genetic Skin Disease; Eczema Intervention: Sponsors: The University of Hong Kong; The Hong Kong Polytechnic University Recruiting
Publication date: Available online 6 November 2019Source: IDCasesAuthor(s): Cristián Vera-Kellet, Catalina Hasbún-Zegpi
CBS Miami anchor Frances Wang, 27, has returned to work after taking a month off to treat perioral dermatitis, a skin condition that occurs due to prolonged use of creams for eczema.
Conditions: Breast Cancer; Radiotherapy; Adverse Effect, Dermatitis or Eczema; Radiotherapy Side Effect; Radiation Burn; Radiation Dermatitis; Radiotherapy; Complications Intervention: Device: Mepitel Film® Sponsor: Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute) Not yet recruiting
New research implicates the nervous system, which was already known to be responsible for the inflammation of atopic dermatitis, but is now being blamed for the itchiness as well.Medscape Medical News
Abstract Patients with atopic dermatitis (AD) have an increased risk of bacterial skin infections that cause significant morbidity and, if untreated, may become systemic. Staphylococcus aureus (S. aureus) colonizes the skin of most AD subjects and is the most common organism to cause infections. Overt bacterial infection is easily recognised by the appearance of weeping lesions, honey-coloured crusts, and pustules. However, the wide variability in clinical presentation of bacterial infection in AD and the inherent features of AD - cutaneous erythema and warmth, oozing associated with oedema, and regional lymphaden...